PPARG and breast carcinoma: Activated PPARγ enables ERBB2-positive breast cancer cells that produce high levels of fat to convert fatty acids into triglycerides, allowing these cells to avoid cell death caused by lipotoxicity (Kourtidis et al., 2009).